🔥🐔 BizChicken 🐔🔥

Companies Similar to Avid Bioservices, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Biogen Inc.

Biogen Inc. logo
Market Cap: Highest
Employees: Highest

TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS

Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.

Tags: biotechnology, multiple sclerosis, neurodegenerative diseases, neurological diseases, pharmaceuticals

Symbol: BIIB

Recent Price: $150.19

Industry: Drug Manufacturers - General

CEO: Mr. Christopher A. Viehbacher

Sector: Healthcare

Employees: 7570

Address: 225 Binney Street, Cambridge, MA 02142

Phone: 617 679 2000

Leadership

  • Christopher A. Viehbacher, President and Chief Executive Officer
  • Susan H. Alexander, Chief Legal Officer
  • Ginger Gregory, Ph.D., Chief Human Resources Officer
  • Jane Grogan, Ph.D., Head of Research
  • Rachid Izzar, Head of Global Product Strategy & Commercialization
  • Adam Keeney, Head of Corporate Development
  • Michael McDonnell, Chief Financial Officer
  • Nicole Murphy, Head of Pharmaceutical Operations and Technology
  • Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
  • Alisha Alaimo, President, Head of North America
  • Stephen Amato, Head of Investor Relations
  • Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
  • Fraser Hall, President, Head of Intercontinental Region
  • Wolfram Schmidt, President, Head of Europe
  • Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
  • Caroline Dorsa, Chair of the Board
  • Maria C. Freire, Ph.D., Director
  • William A. Hawkins, Director
  • Susan Langer, Director
  • Jesus B. Mantas, Director
  • Lloyd B. Minor, M.D., Director
  • Monish Patolawala, Director
  • Eric K. Rowinsky, M.D., Director
  • Stephen A. Sherwin, M.D., Director

Last updated: 2024-12-31

Anixa Biosciences, Inc.

Anixa Biosciences, Inc. logo
Market Cap: Low
Employees: Lowest

Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines

Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.

Tags: CAR-T therapy, COVID-19, anti-viral drugs, biotechnology, infectious diseases, oncology, vaccine development

Symbol: ANIX

Recent Price: $2.50

Industry: Biotechnology

CEO: Dr. Amit Kumar Ph.D.

Sector: Healthcare

Employees: 4

Address: 3150 Almaden Expressway, San Jose, CA 95118

Phone: 408 708 9808

Last updated: 2024-12-31

ImmunityBio, Inc.

ImmunityBio, Inc. logo
Market Cap: High
Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

Absci Corporation

Absci Corporation logo
Market Cap: Medium
Employees: Low

Integrated Drug Creation Platform

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its platform enables the creation of biologics by unifying the drug discovery and cell line development processes.

Tags: AI, biologics, cell line development, drug discovery, pharmaceuticals

Symbol: ABSI

Recent Price: $2.65

Industry: Biotechnology

CEO: Mr. Sean McClain

Sector: Healthcare

Employees: 155

Address: 18105 SE Mill Plain Boulevard, Vancouver, WA 98683

Phone: 360 949 1041

Last updated: 2024-12-31

ADMA Biologics, Inc.

ADMA Biologics, Inc. logo
Market Cap: High
Employees: Medium

BIVIGAM, ASCENIV, Nabi-HB

ADMA Biologics, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing specialty plasma-derived biologics for treating immune deficiencies and infectious diseases.

Tags: biologics, biopharmaceutical, immunodeficiency, infectious diseases, plasma-derived

Symbol: ADMA

Recent Price: $17.49

Industry: Biotechnology

CEO: Mr. Adam S. Grossman

Sector: Healthcare

Employees: 624

Address: 465 State Route 17, Ramsey, NJ 07446

Phone: 201 478 5552

Leadership

  • Adam S. Grossman, Founder, Director, President, & Chief Executive Officer
  • Kaitlin Kestenberg, Chief Operating Officer & Senior Vice President of Compliance
  • Brad Tade, Chief Financial Officer & Treasurer
  • Doug Chambers, Vice President, Quality
  • Daniel Garcia, Vice President, IgG Product Management
  • Jeffrey Janek, Vice President, Production Operations
  • Michael Least, Vice President, Market Access & National Accounts
  • Drew Pantello, Vice President, Marketing & Corporate Development
  • Cindy Petersen, Vice President, Human Resources
  • Michael Space, Vice President, Long Range Planning & Analysis
  • Shane Stremming, Vice President, Operations for ADMA BioCenters
  • Jeffrey Gruenglas, Executive Director, Government Affairs, Health Policy & Scientific Communications
  • John Hafl, Executive Director, Sales
  • Sheri Klostermeyer, Executive Director, Supply Chain
  • Steven A. Elms, Chairman
  • Jerrold B. Grossman, D.P.S., Founder & Vice Chairman
  • Alison C. Finger, Director
  • Bryant E. Fong, Director
  • Lawrence P. Guiheen, Director
  • Young T. Kwon, PhD, Director

Last updated: 2024-12-31

Assembly Biosciences, Inc.

Assembly Biosciences, Inc. logo
Market Cap: Low
Employees: Low

Vebicorvir

Assembly Biosciences, Inc. is a clinical-stage biotechnology company focused on discovering and developing therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Their lead product candidate, Vebicorvir, has completed Phase 2 clinical trials. The company is engaged in additional development and collaboration agreements to advance treatments for HBV.

Tags: Vebicorvir, biotechnology, clinical trials, hepatitis B, therapeutics

Symbol: ASMB

Recent Price: $16.03

Industry: Biotechnology

CEO: Mr. Jason A. Okazaki

Sector: Healthcare

Employees: 65

Address: 331 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 833 509 4583

Last updated: 2024-12-31

Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logo
Market Cap: Medium
Employees: Lowest

ANAVEX 2-73

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.

Tags: Alzheimer's, CNS diseases, Parkinson's, Rett syndrome, biopharmaceutical, clinical trials, neurodegenerative diseases

Symbol: AVXL

Recent Price: $11.04

Industry: Biotechnology

CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.

Sector: Healthcare

Employees: 40

Address: 51 West 52nd Street, New York, NY 10019

Phone: 844 689 3939

Last updated: 2024-12-31

BeiGene, Ltd.

BeiGene, Ltd. logo
Market Cap: Highest
Employees: Highest

BRUKINSA, Tislelizumab, REVLIMID, VIDAZA, XGEVA, BLINCYTO, KYPROLIS, SYLVANT, QARZIBA, Pamiparib, Pobevcy

Bei Gene, Ltd. is a biotechnology company focused on discovering, developing, manufacturing, and commercializing a wide range of medicines globally, specializing in oncology treatments and clinical stage drug candidates.

Tags: Biotechnology, Medicines, Oncology, Pharmaceuticals, Research and Development

Symbol: BGNE

Recent Price: $183.81

Industry: Biotechnology

CEO: Mr. John V. Oyler

Sector: Healthcare

Employees: 10000

Address: 55 Cambridge Parkway, Cambridge, MA 02142

Phone: 781-801-1800

Leadership

  • John V. Oyler, Co-Founder, Chairman and CEO
  • Xiaodong Wang, Ph.D., Co-Founder, Chairman of Scientific Advisory Board
  • Olivier Brandicourt, M.D., Director
  • Margaret Dugan, M.D., Director
  • Donald W. Glazer, Director
  • Michael Goller, Director
  • Anthony Hooper, Director
  • Ranjeev Krishana, Director
  • Michael Nuoqing Yi, Director
  • Alessandro Riva, M.D., Director
  • Corsee Sanders, Ph.D., Director
  • Shalini Sharp, Director
  • Steven Young, Ph.D., Acting Head of Medicinal Chemistry
  • Ron Levy, M.D., Scientific Advisory Board
  • Neal Rosen, M.D., Ph.D., Scientific Advisory Board
  • Charles Sawyers, M.D., Scientific Advisory Board
  • David Schenkein, M.D., Scientific Advisory Board
  • Melika Davis, SVP & Global Head, Clinical Operations
  • Clare Fisher, SVP, Business Development, Licensing, and M&A (ex-China)
  • Tony Guo, Ph.D., SVP, Global Statistics & Data Science
  • Dany Habr, M.D., Head of Medical Affairs, North America & International Markets
  • Graham Hardiman, Global Head of HR
  • Shreya Devendra Jani, SVP, Corporate Affairs
  • Jaspreet Jaggi, M.D., Ph.D., SVP and Head, Clinical Portfolio Strategy
  • Yang Ji, Chief Compliance Officer
  • Mark Lanasa, M.D., Ph.D., SVP, Chief Medical Officer, Solid Tumors
  • Chan Lee, General Counsel
  • Kyu-Sung Lee, Ph.D., SVP, Global Head of Technical Operations and Manufacturing
  • Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer
  • Kyoung Lim, VP of Supply Chain
  • Han Ma, M.D., Ph.D., Chief Safety Officer and SVP, Global Patient Safety
  • Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology
  • Richard O’Keeffe, Head of Global Quality
  • Jurij Petrin, M.D., Head of New Market Development
  • Yan Qi, Ph.D., SVP, Head of Public Affairs
  • Hongyu Qian, SVP, Medical Affairs
  • Jason Radford, SVP, Strategy & Corporate Development
  • Anand Reddi, VP, Global Strategic Initiatives and Corporate Operations, Chief of Staff to the CEO
  • Adam Roach, VP and Head of Asia Pacific
  • Aaron Rosenberg, Chief Financial Officer
  • Michael Schoen, Strategic Advisor and Special Assistant to the CEO
  • Matt Shaulis, General Manager of North America
  • Lai Wang, Ph.D., Global Head of R&D
  • Zhiwei Wang, Ph.D., SVP, Research Head of Chemistry
  • Beth Wensley, SVP, Head of Portfolio and Program Management
  • Kimberly Wolf, SVP, Global Commercial Strategy & Operations
  • Xiaobin Wu, Ph.D., President, Chief Operating Officer
  • Eva Yin, Chief Commercial Officer, Greater China

Last updated: 2024-12-31

bluebird bio, Inc.

bluebird bio, Inc. logo
Market Cap: Low
Employees: Medium

betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel

bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.

Tags: betibeglogene autotemcel, biotechnology, elivaldogene autotemcel, gene therapy, genetic diseases, lovotibeglogene autotemcel

Symbol: BLUE

Recent Price: $7.86

Industry: Biotechnology

CEO: Mr. Andrew Obenshain

Sector: Healthcare

Employees: 375

Address: 60 Binney Street, Cambridge, MA 02142

Phone: 339 499 9300

Leadership

  • Sarah Alspach, Senior Vice President, External Affairs
  • Rich Colvin, MD, PhD, Chief Medical Officer
  • Kasra Kasraian, Senior Vice President, Technical Development and Operations
  • Tom Klima, Chief Commercial & Operating Officer
  • Andrew Obenshain, Chief Executive Officer
  • Scott Shoemaker, Senior Vice President, Quality
  • James Sterling, Chief Financial Officer
  • Joe Vittiglio, Chief Business and Legal Officer
  • Andrea Walton, Chief People Officer
  • Leslie Wilder, Vice President, Head of Regulatory Science
  • Mark Vachon, Chairman; Formerly of GE
  • John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
  • Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
  • Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
  • Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
  • Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
  • Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
  • Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. logo
Market Cap: Highest
Employees: High

Vimizim

Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.

Tags: biotechnology, enzyme replacement therapy, healthcare, pharmaceutical, rare diseases

Symbol: BMRN

Recent Price: $65.45

Industry: Biotechnology

CEO: Mr. Alexander Hardy

Sector: Healthcare

Employees: 3401

Address: 770 Lindaro Street, San Rafael, CA 94901

Phone: 415 506 6700

Leadership

  • Mark Enyedy,
  • Alexander Hardy,
  • Elaine J. Heron,
  • G. Eric Davis, Executive Vice President, Chief Legal Officer
  • Greg Friberg, Executive Vice President, Chief Research & Development Officer
  • C. Greg Guyer, Executive Vice President, Chief Technical Officer
  • Cristin Hubbard, Executive Vice President, Chief Commercial Officer
  • Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
  • Brian R. Mueller, Executive Vice President, Chief Financial Officer
  • James Sabry, Executive Vice President, Chief Business Officer
  • Amy Wireman, Executive Vice President, Chief People Officer
  • Richard A. Meier,
  • Elizabeth McKee Anderson,
  • Barbara Bodem,
  • Athena Countouriotis,
  • Willard H. Dere,
  • Maykin Ho,
  • Robert J. Hombach,
  • David E.I. Pyott,

Last updated: 2024-12-31

Harvard Bioscience, Inc.

Harvard Bioscience, Inc. logo
Market Cap: Low
Employees: Medium

cellular and molecular technology instruments

Harvard Bioscience, Inc. develops, manufactures, and sells technologies and services that support research, discovery, and pre-clinical testing for drug development globally, offering a wide range of instruments for tissue and organ-based lab research.

Tags: biotech, drug development, laboratory instruments, precision measuring, research

Symbol: HBIO

Recent Price: $2.02

Industry: Medical - Instruments & Supplies

CEO: Mr. James W. Green

Sector: Healthcare

Employees: 391

Address: 84 October Hill Road, Holliston, MA 01746

Phone: 508 893 8999

Leadership

  • James Green, Chairman, President & Chief Executive Officer
  • Jennifer Cote, Chief Financial Officer and Treasurer
  • John Fry, Chief Legal Counsel and Corporation Secretary
  • Diane Houston, Vice President, Global IT
  • Lori Packer, Vice President, Global People Operations
  • Nitya Shetty, Vice President, Global Research and Development
  • Ryan Wallace, Senior Vice President, Global Sales

Last updated: 2024-12-31

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc. logo
Market Cap: High
Employees: Medium

Nucleic Acids and Biologics Safety Testing Products

Maravai Life Sciences Holdings, Inc. is a life sciences company that provides products for drug therapies, diagnostics, novel vaccines, and research on human diseases, serving both the United States and international markets.

Tags: Biologics Safety, Biopharmaceutical, Gene Therapy, Life Sciences, Molecular Diagnostics, Nucleic Acids

Symbol: MRVI

Recent Price: $5.51

Industry: Biotechnology

CEO: Mr. William E. Martin III

Sector: Healthcare

Employees: 580

Address: 10770 Wateridge Circle, San Diego, CA 92121

Phone: 858 546 0004

Last updated: 2024-12-31

Repligen Corporation

Repligen Corporation logo
Market Cap: Highest
Employees: High

bioprocessing technologies and systems

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing worldwide, offering products like Protein A ligands, chromatography columns, ELISA test kits, and filtration products.

Tags: ELISA test kits, Protein A ligands, biologics purification, bioprocessing, chromatography, filtration systems

Symbol: RGEN

Recent Price: $143.81

Industry: Medical - Instruments & Supplies

CEO: Mr. Olivier Loeillot

Sector: Healthcare

Employees: 1783

Address: Building 1, Waltham, MA 02453

Phone: 781 250 0111

Leadership

  • Mark A. Gambino, President and CEO
  • Pradeep K. Gohil, Chief Financial Officer
  • Matthew B. Wrobel, Chief Technology Officer
  • Claudia A. Grunewald, Director of Quality Assurance
  • Mickey R. Perry, Chief Operating Officer
  • Paul C. Miller, General Counsel and Secretary
  • James J. O'Brien, Chairman of the Board
  • Diane Williams, Board Member
  • Charles A. Jamieson, Board Member
  • Rebecca D. Faulkner, Board Member

Last updated: 2024-12-31

Jabil Inc.

Jabil Inc. logo
Market Cap: Highest
Employees: Highest

Manufacturing Services and Solutions

Jabil Inc. provides comprehensive manufacturing services and solutions globally, operating in Electronics Manufacturing Services and Diversified Manufacturing Services segments. They specialize in electronics design, production, and product management services, including integrated circuit design, electro-mechanical assemblies, and industrial design.

Tags: Design, Electronics, Industrial Design, Manufacturing, Production

Symbol: JBL

Recent Price: $143.76

Industry: Hardware, Equipment & Parts

CEO: Mr. Michael Dastoor

Sector: Technology

Employees: 138000

Address: 10560 Dr. Martin Luther King, Saint Petersburg, FL 33716

Phone: 727 577 9749

Leadership

  • Mark T. Mondello, Executive Chairman of the Board of Directors
  • Steven A. Raymund, Lead Director
  • Anousheh Ansari, Director
  • Christopher S. Holland, Director
  • John Plant, Director
  • Jamie Siminoff, Director
  • David M. Stout, Director
  • Tiger Tyagarajan, Director
  • Kathy Walters, Director
  • Mike Dastoor, Chief Executive Officer
  • Greg Hebard, Chief Financial Officer
  • Frederic McCoy, Executive Vice President, Operations
  • Steve Borges, Executive Vice President, Global Business Units
  • Matt Crowley, Executive Vice President, Global Business Units
  • Andy Priestley, Executive Vice President, Global Business Units
  • Adam Berry, Senior Vice President, Investor Relations and Communications
  • Frank McKay, Senior Vice President, Chief Supply Chain & Procurement Officer
  • Kristine Melachrino, Senior Vice President, General Counsel
  • Gary Schick, Senior Vice President, Chief Human Resources Officer
  • May Yap, Senior Vice President, Chief Information Officer

Last updated: 2024-12-31

Avient Corporation

Avient Corporation logo
Market Cap: High
Employees: Highest

Sustainable Material Solutions

Avient Corporation provides specialized formulator services and sustainable material solutions across multiple regions including the United States, Canada, Europe, and Asia, through a variety of product segments.

Tags: Color Concentrates, Distribution, Engineered Materials, Material Solutions, Sustainability

Symbol: AVNT

Recent Price: $40.12

Industry: Chemicals - Specialty

CEO: Dr. Ashish K. Khandpur Ph.D.

Sector: Basic Materials

Employees: 9300

Address: 33587 Walker Road, Avon Lake, OH 44012

Phone: 440 930 1000

Last updated: 2024-12-31

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation logo
Market Cap: Medium
Employees: Medium

immunoSEQ

Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.

Tags: COVID-19, cancer, diagnostics, immune medicine, immunosequencing, translational research

Symbol: ADPT

Recent Price: $6.11

Industry: Biotechnology

CEO: Mr. Chad M. Robins M.B.A.

Sector: Healthcare

Employees: 709

Address: 1165 Eastlake Avenue East, Seattle, WA 98109

Phone: 206 659 0067

Last updated: 2024-12-31

BioLife Solutions, Inc.

BioLife Solutions, Inc. logo
Market Cap: Medium
Employees: Medium

bioproduction tools and services

Bio Life Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services essential for the cell and gene therapy industry globally. The company's offerings include biopreservation media products, automated thawing products, cloud-connected shipping containers, and storage solutions for biologics and pharmaceuticals.

Tags: biological storage, biologics, biopreservation, cell therapy, cryogenic equipment, gene therapy, pharmaceuticals, temperature-sensitive storage

Symbol: BLFS

Recent Price: $26.27

Industry: Medical - Instruments & Supplies

CEO: Mr. Roderick de Greef

Sector: Healthcare

Employees: 409

Address: 3303 Monte Villa Parkway, Bothell, WA 98021

Phone: 425 402 1400

Leadership

  • Rod de Greef, Chairman & Chief Executive Officer
  • Aby J. Mathew, Ph.D., Executive Vice President and Chief Scientific Officer
  • Karen Foster, Chief Quality and Operations Officer
  • Troy Wichterman, Chief Financial Officer
  • Todd Berard, Chief Marketing Officer
  • Garrie Richardson, Chief Revenue Officer
  • Sarah Aebersold, Chief Human Resources Officer
  • Mike Pallotta, Global VP, Hardware and Electrical Engineering
  • Brett Stucker, VP of Cybersecurity and Information Security Officer
  • Amy DuRoss,
  • Rachel Ellingson,
  • Joydeep Goswami, MBA, Ph.D.,
  • Tim Moore,
  • Joseph Schick, Chairman – Audit Committee
  • Andrew Hinson,
  • Anthony Davies, Ph.D.,
  • Colleen Delaney, M.D., M.Sc.,
  • Dayong Gao, Ph.D.,
  • Erik Woods, Ph.D., HCLD(ABB),
  • Jon Rowley, Ph.D.,
  • John McMannis, Ph.D.,
  • Jerry E. Cooley, M.D.,
  • Jason Acker, MBA, Ph.D.,
  • Lizabeth Cardwell, MT (ASCP), MBA, RAC,
  • Scott R. Burger, M.D.,
  • Shelly Heimfeld, Ph.D.,

Last updated: 2024-12-31

Avid Bioservices, Inc.

Avid Bioservices, Inc. logo
Market Cap: Medium
Employees: Medium

Biopharmaceutical Manufacturing Services

Avid Bioservices, Inc., a contract development and manufacturing organization, offers process development and CGMP manufacturing services for biopharmaceutical drug substances derived from mammalian cell culture, serving the biotechnology and biopharmaceutical industries.

Tags: CGMP, biopharmaceutical, manufacturing, monoclonal antibodies, process development, recombinant proteins

Symbol: CDMO

Recent Price: $12.33

Industry: Biotechnology

CEO: Mr. Nicholas Stewart Green B.Sc., MBA

Sector: Healthcare

Employees: 371

Address: 2642 Michelle Drive, Tustin, CA 92780

Phone: 714 508 6100

Last updated: 2024-12-31

Avidity Biosciences, Inc.

Avidity Biosciences, Inc. logo
Market Cap: High
Employees: Low

AOC 1001, AOC 1044, AOC 1020, Lumizyme

Avidity Biosciences, Inc. is a biopharmaceutical company focused on the development of oligonucleotide-based therapies, including antibody oligonucleotide conjugates (AOC) for serious diseases such as myotonic dystrophy type 1, Duchenne Muscular Dystrophy, and facioscapulohumeral muscular dystrophy.

Tags: Duchenne Muscular Dystrophy, Pompe disease, antibody oligonucleotide conjugates, biopharmaceutical, facioscapulohumeral muscular dystrophy, myotonic dystrophy, oligonucleotide, therapies

Symbol: RNA

Recent Price: $29.18

Industry: Biotechnology

CEO: Ms. Sarah Boyce

Sector: Healthcare

Employees: 253

Address: 10578 Science Center Drive, San Diego, CA 92121

Phone: 858 401 7900

Leadership

  • Troy Wilson, PhD, JD, Board Chair and Co-Founder, Chief Executive Officer and Director, Kura Oncology
  • Carsten Boess, Board Member
  • Noreen Henig, M.D., Board Member
  • Jean Kim, Board Member
  • Edward Kaye, M.D., Chief Executive Officer and Director, Stoke Therapeutics
  • Simona Skerjanec, Board Member
  • Tamar Thompson, VP, Govt. Affairs and Policy, Alexion Pharmaceuticals
  • Sarah Boyce, President & Chief Executive Officer, Avidity Biosciences
  • Arthur A. Levin, PhD, Distinguished Scientist and Strategic Leader, Avidity Biosciences

Last updated: 2024-12-31